| Detected | Trial | Change |
|---|---|---|
| 2026-05-23 | NCT05208047 (Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With… |
Trial arms changed: 6 -> 7 |
| 2026-05-23 | NCT05208047 (Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With… |
date change Completion pushed: 2026-09 -> 2030-01 |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT05208047 | (Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With… | Advanced Gastrointestinal Stromal Tumors | Active, Not Recruiting |
| Phase 2 | |||
| NCT04996875 | (Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis | Advanced Systemic Mastocytosis (AdvSM) | Recruiting |
| NCT07204964 | A Study to Evaluate the Immune Response and Safety of an Influenza Vaccine in Adults 18… | Influenza, Human | Active, Not Recruiting |
| NCT05186753 | (Summit) A Study to Evaluate the Efficacy and Safety of CGT9486 Versus Placebo in… | SSM | Active, Not Recruiting |